You just read:

Merck Announces Positive Study Investigating the Use of Pembrolizumab Compared to Chemotherapy in Patients with Ipilimumab-Refractory Advanced Melanoma

News provided by

Merck Canada Inc.

Nov 16, 2014, 04:25 ET